CN109316507A - 一种老鹰茶的渗漉提取方法 - Google Patents
一种老鹰茶的渗漉提取方法 Download PDFInfo
- Publication number
- CN109316507A CN109316507A CN201811263058.XA CN201811263058A CN109316507A CN 109316507 A CN109316507 A CN 109316507A CN 201811263058 A CN201811263058 A CN 201811263058A CN 109316507 A CN109316507 A CN 109316507A
- Authority
- CN
- China
- Prior art keywords
- hawk tea
- tea
- ethyl alcohol
- percolation extraction
- hawk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001122767 Theaceae Species 0.000 title claims abstract description 32
- 238000000605 extraction Methods 0.000 title claims abstract description 13
- 238000005325 percolation Methods 0.000 title claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000019441 ethanol Nutrition 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 11
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 230000002075 anti-alcohol Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 241000587213 Litsea coreana Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001081179 Litsea Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- -1 polyphenol compound Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Abstract
本发明涉及一种老鹰茶的渗漉提取方法，其特征在于包含以下步骤：取老鹰茶粉碎，过10‑30目筛，称定重量置渗漉柱中，加入1‑12倍药材量的80％‑95％乙醇进行渗漉，收集渗漉液，减压回收乙醇，真空干燥即得老鹰茶提取物。本发明一种老鹰茶的渗漉提取方法的有益效果：操作简单产量高，可实现规模化生产。
Description
技术领域
本发明涉及一种老鹰茶的渗漉提取方法。
背景技术
老鹰茶是樟科木姜子属的木本植物，学名毛豹皮樟，在四川、贵州、湖南、湖北等南方各省都有分布，属常绿乔木，叶互生，叶质厚，色泽深绿。在恩施山区广有分布，目前仍处于野生状态，建始、咸丰两县多年以来就有制作饮用老鹰茶的习惯，采其嫩枝嫩叶稍作加工制干后，可当茶泡饮，当地称它为老鹰茶。老鹰茶含芳香油很多，也含多酚类化合物，泡饮时较清香，滋味厚实，先涩后甘，滋味浓而口劲大，在夏天饮用更觉得消暑解渴、提神助兴，在民间有消暑和健胃开脾的说法。《本草纲目》中有“止咳、祛痰、平喘、消暑解渴”等记载。
目前，老鹰红茶经国家农业部食品质量监督检测中心检测出，老鹰茶含多种成分，如矿物质元素、维生素C1、维生素B2、氨基酸(含0.76％)、含硒(0.16mg/kg)、含铁(128mg/kg)、含锌(38.6mg/kg)、总黄酮(3.32％)、多酚类等17种人体所需的微量元素，有利于改善造血系统和内分泌系统的功能，对提高免疫力、抗癌、脑神经和心血管具有保健作用。古代医学家李时珍在《本草纲目》中对老鹰茶有止咳、去痰、平喘、解署、解渴等功效的记载。该产品上市以来，以其独特的品质呈现供不应求的局面，老鹰红茶新产品将会成为恩施州茶叶产业的新兴的生力军。
近年来，人们的应酬越来越多，饮酒已成为一种习俗，一种沟通感情的方式，可以给人们带来热情、兴奋、甚至灵感。但是饮酒时常给人带来胃肠不适、恶心呕吐、心神烦乱、头晕目眩等不适症状，甚至因过量饮酒而经常引发各种意外，给社会和人体健康带来各种隐患。长期过量饮酒，还会加重肝脏负担，严种损伤肝脏，造成脂肪肝、酒精肝、肝炎、肝硬化等疾病，而现代医学治疗酒精性肝病目前只有戒酒，对症治疗，并无特效药。
降低体内血中乙醇及其代谢产物的浓度是解酒药物的作用关键，减轻其对各器官的损伤。当前的解酒产品主要在以下两个方面发挥解酒作用。第一，解酒药物抑制酒精的胃肠吸收，加强乙醇在胃肠道首过效应，降低血中乙醇浓度；第二，解酒药物直接作用于肝代谢的酶系，加速乙醇及其代谢产物的消除速率，减轻其对细胞和组织的损害。长期以来，通过化学合成的方法研制解酒护肝药物并未取得大的突破。现有市售具有解酒的产品多以葛根、灵芝、维生素、水飞蓟、五味子、枸杞、枳椇子为主的保健产品多产自美国和日本，产品有胶囊、片剂、茶和功能饮料等剂型，主要功效为解酒保肝。
老鹰茶其生长、成活与否对土壤、日照、气温、降水等条件均有严格要求。老鹰茶具有清热解毒、退黄化湿，活血散瘀，利水消肿之功效，是苗族民间治疗肝病的经验方，苗族人世代习用，称她为“神仙茶”。现代研究表明老鹰茶内含多种有效成份均对肝损伤具保护作用，能恢复肝脏功能，减低饮酒及药物对肝脏的损害，抑制肝纤维化、肝硬化，并对甲肝、乙肝、慢性活动性肝炎具有显著的治疗作用。
发明内容
本发明的目的是提供一种老鹰茶的渗漉提取方法。
本发明一种老鹰茶的渗漉提取方法，其特征在于包含以下步骤：
取老鹰茶粉碎，过10-30目筛，称定重量置渗漉柱中，加入1-12倍药材量的80％-95％乙醇进行渗漉，收集渗漉液，减压回收乙醇，真空干燥即得老鹰茶提取物。
本发明是将老鹰茶中提取的提取物应用在预防醉酒、解酒及对化学性肝损伤具有辅助作用中。由于老鹰茶提取物提取难度大、低溶解性、稳定性差等特点，极大地限制其在功能保健品中的应用，且将老鹰茶提取物应用于解酒产品中还未见相关报道。因此以老鹰茶提取物为基础，开发具有自主知识产权的系列解酒功能食品和保健品具有广阔的应用前景。
本发明一种老鹰茶的渗漉提取方法的有益效果：操作简单产量高，可实现规模化生产。
具体实施方式
下面结合实施例对本发明作进一步详细的描述，但发明的实施方式不限于此。
实施例1：一种老鹰茶的渗漉提取方法，其特征在于包含以下步骤：
取老鹰茶药材粉碎，过10目筛，称定重量置渗漉柱中，加入1倍药材量的80％乙醇进行渗漉，收集渗漉液，减压回收乙醇，真空干燥即得老鹰茶提取物。
实施例2：一种老鹰茶的渗漉提取方法，其特征在于包含以下步骤：
取老鹰茶材粉碎，过30目筛，称定重量置渗漉柱中，加入12倍药材量的95％乙醇进行渗漉，收集渗漉液，减压回收乙醇，真空干燥即得老鹰茶提取物。
实施例3：一种老鹰茶的渗漉提取方法，其特征在于包含以下步骤：
取老鹰茶材粉碎，过20目筛，称定重量置渗漉柱中，加入6倍药材量的90％乙醇进行渗漉，收集渗漉液，减压回收乙醇，真空干燥即得老鹰茶提取物。
Claims (1)
1.一种老鹰茶的渗漉提取方法，其特征在于包含以下步骤：
取老鹰茶干叶粉碎，过10-30目筛，称定重量置渗漉柱中，加入1-12倍药材量的80％-95％乙醇进行渗漉，收集渗漉液，减压回收乙醇，真空干燥即得老鹰茶提取物。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811263058.XA CN109316507A (zh) | 2018-10-27 | 2018-10-27 | 一种老鹰茶的渗漉提取方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811263058.XA CN109316507A (zh) | 2018-10-27 | 2018-10-27 | 一种老鹰茶的渗漉提取方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109316507A true CN109316507A (zh) | 2019-02-12 |
Family
ID=65259654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811263058.XA Pending CN109316507A (zh) | 2018-10-27 | 2018-10-27 | 一种老鹰茶的渗漉提取方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109316507A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101099523A (zh) * | 2007-07-28 | 2008-01-09 | 舒阿庆 | 从老鹰茶中提取茶多酚的方法 |
| CN101575326A (zh) * | 2009-06-25 | 2009-11-11 | 合肥工业大学 | 从老鹰茶中提取茶多酚的方法 |
| CN104096380A (zh) * | 2013-04-15 | 2014-10-15 | 天津天士力现代中药资源有限公司 | 一种高效渗漉提取中药有效成分的方法 |
| CN104336775A (zh) * | 2013-07-26 | 2015-02-11 | 江西中烟工业有限责任公司 | 一种老鹰茶提取物及其制备方法以及该提取物在卷烟中的应用 |
| CN106665982A (zh) * | 2016-11-24 | 2017-05-17 | 重庆龙鼎茶业有限公司 | 老鹰茶的制备方法 |
| CN107156377A (zh) * | 2017-05-25 | 2017-09-15 | 四川鹅背山茶业股份有限公司 | 一种制备茶饮料的方法 |
-
2018
- 2018-10-27 CN CN201811263058.XA patent/CN109316507A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101099523A (zh) * | 2007-07-28 | 2008-01-09 | 舒阿庆 | 从老鹰茶中提取茶多酚的方法 |
| CN101575326A (zh) * | 2009-06-25 | 2009-11-11 | 合肥工业大学 | 从老鹰茶中提取茶多酚的方法 |
| CN104096380A (zh) * | 2013-04-15 | 2014-10-15 | 天津天士力现代中药资源有限公司 | 一种高效渗漉提取中药有效成分的方法 |
| CN104336775A (zh) * | 2013-07-26 | 2015-02-11 | 江西中烟工业有限责任公司 | 一种老鹰茶提取物及其制备方法以及该提取物在卷烟中的应用 |
| CN106665982A (zh) * | 2016-11-24 | 2017-05-17 | 重庆龙鼎茶业有限公司 | 老鹰茶的制备方法 |
| CN107156377A (zh) * | 2017-05-25 | 2017-09-15 | 四川鹅背山茶业股份有限公司 | 一种制备茶饮料的方法 |
Non-Patent Citations (1)
| Title |
|---|
| "老鹰茶的化学成分研究": ""老鹰茶的化学成分研究"", 《安徽医科大学学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103719498B (zh) | 一种提高免疫力的黄精保健茶及其制备方法 | |
| CN1840166A (zh) | 温胆汤现代中药口服制剂及其生产方法 | |
| CN107950929A (zh) | 一种具有改善睡眠功能的组合物及其制备方法和用途 | |
| CN103301267A (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
| CN103142916B (zh) | 一种预防和治疗老年性痴呆病的药物 | |
| CN102764294B (zh) | 一种祛痰止咳组合物及其制备方法 | |
| CN104474472A (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
| CN102552692B (zh) | 金线莲复方解酒保肝胶囊及其制备方法 | |
| CN102178721B (zh) | 绞股蓝混悬液、提取物在制备治疗抗抑郁症药物中的应用 | |
| CN109674848A (zh) | 一种甘草提取物的制备方法与用途 | |
| CN101390970B (zh) | 一种治疗乙肝的中药及其制备方法 | |
| CN101199652B (zh) | 治疗急性、亚急性湿疹的药物及其制备方法 | |
| CN104383232B (zh) | 清热解毒苦丁茶含片及其生产方法 | |
| CN109316507A (zh) | 一种老鹰茶的渗漉提取方法 | |
| CN100528170C (zh) | 芒果叶提取物制剂及其生产方法 | |
| CN101214325B (zh) | 复方陈香胃药物的制备方法及其新用途 | |
| CN101264171A (zh) | 一种用于戒毒的中药组合物及其制备方法和其应用 | |
| CN101433577A (zh) | 一种绿豆解酒剂及其制备方法 | |
| CN102512481B (zh) | 雷公藤胶囊剂及其应用 | |
| CN109453249B (zh) | 防治药物性肝损伤的药物组合物及不同剂型的制备方法 | |
| CN109125623A (zh) | 一种用于治疗肝病的药物组合物 | |
| CN102451274A (zh) | 功劳去火的中药制剂 | |
| CN102485263A (zh) | 一种治疗小儿久咳的药物组合物及制备方法 | |
| CN102145113B (zh) | 一种化痰平喘的中药组合物及其制备方法 | |
| CN102335345A (zh) | 一种滋阴清热润肺止嗽的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190212 |
|
| RJ01 | Rejection of invention patent application after publication |